Detalhe da pesquisa
1.
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.
Pediatr Infect Dis J
; 29(5): 391-6, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20431379